Since ILC1 is identified in human as ILCs negative for CRTH2, cKit and CD56 expression, we tested whether, in APL patients, the ILC1 fraction comprised also undifferentiated ILC precursors, recently defined by others as CD5+CD1a− ILCs. This evidence concerns the gene PTGDR2 and acute promyelocytic leukemia.